Pei Hu

Author PubWeight™ 38.70‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Quantitative determination of olmesartan in human plasma and urine by liquid chromatography coupled to tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2007 1.46
2 Cerebrospinal fluid concentrations of gefitinib in patients with lung adenocarcinoma. Clin Lung Cancer 2012 1.21
3 Phase I trial of icotinib, a novel epidermal growth factor receptor tyrosine kinase inhibitor, in Chinese patients with non-small cell lung cancer. Chin Med J (Engl) 2011 1.07
4 Calcium absorption measured by stable calcium isotopes ((42)Ca & (44)Ca) among Northern Chinese adolescents with low vitamin D status. J Orthop Surg (Hong Kong) 2002 0.96
5 Safety, pharmacokinetics and pharmacodynamics of single doses of rivaroxaban - an oral, direct factor Xa inhibitor - in elderly Chinese subjects. Thromb Haemost 2009 0.93
6 Determination of free and total vincristine in human plasma after intravenous administration of vincristine sulfate liposome injection using ultra-high performance liquid chromatography tandem mass spectrometry. J Chromatogr A 2012 0.88
7 Determination of ginsenoside Rg3 in human plasma and urine by high performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2010 0.88
8 Use of stable calcium isotopes (42Ca & 44Ca) in evaluation of calcium absorption in Beijing adolescents with low vitamin D status. Food Nutr Bull 2002 0.88
9 Clinical pharmacokinetics of Icotinib, an anti-cancer drug: evaluation of dose proportionality, food effect, and tolerability in healthy subjects. Cancer Chemother Pharmacol 2014 0.87
10 Quantitative determination of icotinib in human plasma and urine using liquid chromatography coupled to tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2009 0.87
11 Measurement of endogenous uracil and dihydrouracil in plasma and urine of normal subjects by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2002 0.87
12 Evaluating a physiologically based pharmacokinetic model for prediction of omeprazole clearance and assessing ethnic sensitivity in CYP2C19 metabolic pathway. Eur J Clin Pharmacol 2015 0.87
13 A phase I study on pharmacokinetics and pharmacodynamics of higenamine in healthy Chinese subjects. Acta Pharmacol Sin 2012 0.86
14 Determination of cinacalcet hydrochloride in human plasma by liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal 2011 0.86
15 Single-dose pharmacokinetics of levetiracetam in healthy Chinese male subjects. Br J Clin Pharmacol 2007 0.86
16 Sexual dysfunction during methadone maintenance treatment and its influence on patient's life and treatment: a qualitative study in South China. Psychol Health Med 2012 0.85
17 TiO2-B nanosheets/anatase nanocrystals co-anchored on nanoporous graphene: in situ reduction-hydrolysis synthesis and their superior rate performance as an anode material. Chemistry 2013 0.85
18 Effect of the CYP2C19 genotype on the pharmacokinetics of icotinib in healthy male volunteers. Eur J Clin Pharmacol 2012 0.84
19 Label-free detection of native proteins by surface-enhanced Raman spectroscopy using iodide-modified nanoparticles. Anal Chem 2014 0.84
20 [Polymorphisms of ERCC1 gene and outcomes in epithelial ovarian cancer patients with platinum-based chemotherapy]. Zhonghua Fu Chan Ke Za Zhi 2013 0.83
21 Nilotinib for imatinib-resistant or -intolerant chronic myeloid leukemia in chronic phase, accelerated phase, or blast crisis: a single- and multiple-dose, open-label pharmacokinetic study in Chinese patients. Clin Ther 2009 0.83
22 Therapeutic effects and adverse drug reactions are affected by icotinib exposure and CYP2C19 and EGFR genotypes in Chinese non-small cell lung cancer patients. Asian Pac J Cancer Prev 2014 0.82
23 The pharmacokinetics, pharmacodynamics, and tolerability of liraglutide, a once-daily human GLP-1 analogue, after multiple subcutaneous administration in healthy Chinese male subjects. J Clin Pharmacol 2011 0.82
24 Bi4Ti3O12 nanofibers-BiOI nanosheets p-n junction: facile synthesis and enhanced visible-light photocatalytic activity. Nanoscale 2013 0.82
25 Antimicrobial N-halamine modified chitosan films. Carbohydr Polym 2012 0.81
26 DNA repair gene associated with clinical outcome of epithelial ovarian cancer treated with platinum-based chemotherapy. Asian Pac J Cancer Prev 2013 0.81
27 Simultaneous determination of blonanserin and its four metabolites in human plasma using ultra-performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2013 0.80
28 Metabolite characterization of a novel anti-cancer agent, icotinib, in humans through liquid chromatography/quadrupole time-of-flight tandem mass spectrometry. Rapid Commun Mass Spectrom 2011 0.80
29 Method transfer, partial validation, and cross validation: recommendations for best practices and harmonization from the global bioanalysis consortium harmonization team. AAPS J 2014 0.80
30 Determination of L-threonate in human plasma and urine by high performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2006 0.80
31 Predicting the outcome of platinum-based chemotherapies in epithelial ovarian cancer using the 8092C/A polymorphism of ERCC1: a meta-analysis. Biomarkers 2014 0.80
32 Pharmacokinetics and safety of calcium L-threonate in healthy volunteers after single and multiple oral administrations. Acta Pharmacol Sin 2011 0.79
33 Electrospun sillenite Bi12MO20 (M = Ti, Ge, Si) nanofibers: general synthesis, band structure, and photocatalytic activity. Phys Chem Chem Phys 2013 0.79
34 Simultaneous quantitative determination of olmesartan and hydrochlorothiazide in human plasma and urine by liquid chromatography coupled to tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2010 0.79
35 [Study on the pharmacokinetic profile of telbivudine]. Zhonghua Gan Zang Bing Za Zhi 2006 0.79
36 Important role of the dihydrouracil/uracil ratio in marked interpatient variations of fluoropyrimidine pharmacokinetics and pharmacodynamics. J Clin Pharmacol 2004 0.78
37 Quantitative determination of atorvastatin and para-hydroxy atorvastatin in human plasma by LC-MS-MS. J Chromatogr Sci 2008 0.78
38 Relative contributions of the major human CYP450 to the metabolism of icotinib and its implication in prediction of drug-drug interaction between icotinib and CYP3A4 inhibitors/inducers using physiologically based pharmacokinetic modeling. Expert Opin Drug Metab Toxicol 2015 0.78
39 Pharmacokinetics, pharmacodynamics, and safety of esomeprazole injection/infusion in healthy Chinese volunteers: a five-way crossover study. J Gastroenterol Hepatol 2013 0.78
40 Pharmacokinetics, pharmacodynamics, and tolerability of single ascending doses of RCT-18 in Chinese patients with rheumatoid arthritis. Clin Pharmacokinet 2014 0.78
41 Pharmacokinetic and pharmacodynamic profiles of a fixed-dose combination of olmesartan medoxomil and amlodipine in healthy Chinese males and females. Clin Drug Investig 2012 0.78
42 Measurement of 1- and 3-methylhistidine in human urine by ultra performance liquid chromatography-tandem mass spectrometry. Clin Chim Acta 2011 0.77
43 Alternative methods for CYP2D6 phenotyping: comparison of dextromethorphan metabolic ratios from AUC, single point plasma, and urine. Int J Clin Pharmacol Ther 2016 0.77
44 BSA-coated nanoparticles for improved SERS-based intracellular pH sensing. Anal Chem 2014 0.77
45 Pharmacokinetics of 8-hour intravenous infusion of NXY-059: a phase I, randomized, double-blind (within dose panels), placebo-controlled study in healthy Chinese volunteers. Clin Ther 2008 0.77
46 Simultaneous determination of olmesartan and amlodipine in human plasma and urine by ultra performance liquid chromatography tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2013 0.77
47 Pharmacokinetics of single and repeated oral doses prucalopride in healthy Chinese volunteers. Int J Clin Pharmacol Ther 2012 0.77
48 Effects of four traditional Chinese medicines on the pharmacokinetics of simvastatin. Xenobiotica 2015 0.75
49 Facile synthesis of defect-rich and S/N co-doped graphene-like carbon nanosheets as an efficient electrocatalyst for primary and all-solid-state Zn-air batteries. ACS Appl Mater Interfaces 2017 0.75
50 A single and multiple postprandial dose study investigating the pharmacokinetics and pharmacodynamics of edoxaban in healthy Chinese volunteers
. Int J Clin Pharmacol Ther 2016 0.75
51 Azospirillum humicireducens sp. nov., a nitrogen-fixing bacterium isolated from a microbial fuel cell. Int J Syst Evol Microbiol 2012 0.75
52 Quantitative determination of buagafuran in human plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2011 0.75
53 Determination of pseudo-ginsenoside GQ in human plasma by high performance liquid chromatography-tandem mass spectrometry. Biomed Chromatogr 2013 0.75
54 Modeling the dermatopharmacokinetic profile of two loxoprofen patches for bioequivalence confirmation. Int J Clin Pharmacol Ther 2015 0.75
55 Single- and multiple-dose pharmacokinetics and tolerability of paroxetine controlled-release tablet in healthy Chinese subjects
. Int J Clin Pharmacol Ther 2016 0.75
56 Pharmacokinetics of vorapaxar and its metabolite following oral administration in healthy Chinese and American subjects. Int J Clin Pharmacol Ther 2014 0.75
57 [Association between ryanodine receptor 2 with cardiovascular diseases]. Zhonghua Xin Xue Guan Bing Za Zhi 2014 0.75
58 Bismuth oxyiodide nanosheets: a novel high-energy anode material for lithium-ion batteries. Chem Commun (Camb) 2015 0.75
59 Pharmacokinetics and tolerability of olmesartan medoxomil plus hydrochlorothiazide combination in healthy Chinese subjects: drug-drug interaction, bioequivalence, and accumulation. Int J Clin Pharmacol Ther 2014 0.75
60 Simultaneous determination of a novel antifibrotic agent and three metabolites in human urine by LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2010 0.75
61 Determination of phenylephrine in human plasma using ultra-performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2012 0.75
62 The polymorphism of CYP2D6 affects the pharmacokinetics and dose escalation of paroxetine controlled-release tablet in healthy Chinese subjects
. Int J Clin Pharmacol Ther 2017 0.75
63 Quantitative determination of omapatrilat and its metabolites in human plasma by HPLC coupled with tandem mass spectrometry. Acta Pharmacol Sin 2003 0.75
64 [Quantification of sitagliptin in human plasma and urine by LC-MS/MS method and its application]. Yao Xue Xue Bao 2015 0.75
65 Bacillus thermocopriae sp. nov., isolated from a compost. Int J Syst Evol Microbiol 2013 0.75
66 [Electron shuttling function of dissolved organic matter]. Huan Jing Ke Xue 2009 0.75
67 A high-performance liquid chromatography-tandem mass spectrometry method coupled with protein precipitation for determination of granisetron in human plasma and its application to a comparative pharmacokinetic study. Biomed Chromatogr 2014 0.75
68 [The stability of synthesized EGFP mRNA in vitro transfected into human umbilical cord mesenchymal stem cells]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2013 0.75
69 Dermatopharmacokinetic bioequivalence study of two types of topical patches containing loxoprofen sodium. Int J Clin Pharmacol Ther 2014 0.75
70 Quantitative determination of trimebutine maleate and its three metabolites in human plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2002 0.75
71 China Bioanalysis Forum. Bioanalysis 2013 0.75
72 [Bioleaching of fly ash from municipal solid waste incinerator using sewage sludge and pig manure as culture media]. Huan Jing Ke Xue 2005 0.75
73 [Interaction of butylphthalide with rat and human liver CYP450 isoenzymes]. Yao Xue Xue Bao 2015 0.75
74 Cytochrome P450 2D6 genotype affects the pharmacokinetics of controlled-release paroxetine in healthy Chinese subjects: comparison of traditional phenotype and activity score systems. Eur J Clin Pharmacol 2015 0.75
75 Determination of nicousamide in human plasma by liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal 2013 0.75
76 The pharmacokinetic and safety profiles of blonanserin in healthy Chinese volunteers after single fasting doses and single and multiple postprandial doses. Clin Drug Investig 2014 0.75
77 Simultaneous determination of a novel anxiolytic agent buagafuran and one metabolite in human plasma by ultra-performance liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal 2012 0.75
78 [Effects of earthworm activity on phosphorus fraction and available phosphorus content in red soil]. Ying Yong Sheng Tai Xue Bao 2005 0.75
79 An open-label, multiple-dose study to assess the pharmacokinetics and tolerability of sitagliptin/metformin fixed-dose combination (FDC) tablet in healthy Chinese adult subjects. Int J Clin Pharmacol Ther 2016 0.75
80 Neuroprotective effect of escitalopram oxalate in rats with chronic hypoperfusion. J Huazhong Univ Sci Technolog Med Sci 2015 0.75
81 Pharmacokinetic and safety profile of olmesartan medoxomil in healthy Chinese subjects after single and multiple administrations. Pharmazie 2009 0.75
82 Pharmacokinetics and safety of paroxetine controlled-release tablet in healthy Chinese subjects: a single-dose three-period crossover study. Int J Clin Pharmacol Ther 2016 0.75
83 Purification and characterization of a novel lectin from Chinese leek seeds. J Agric Food Chem 2015 0.75
84 Calcium bioavailability of calcium L-threonate in healthy Chinese subjects measured with stable isotopes (⁴⁴Ca and ⁴²Ca). Eur J Clin Pharmacol 2012 0.75
85 Investigation of a potential pharmacokinetic interaction between perindopril arginine and amlodipine when administered as a single perindopril/amlodipine fixed-dose combination tablet in healthy Chinese male volunteers. Int J Clin Pharmacol Ther 2016 0.75
86 Determination of higenamine in human plasma and urine using liquid chromatography coupled to positive electrospray ionization tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2011 0.75
87 Bioelectricity generation and microcystins removal in a blue-green algae powered microbial fuel cell. J Hazard Mater 2011 0.75